首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   128篇
  免费   5篇
林业   1篇
  1篇
综合类   37篇
水产渔业   1篇
畜牧兽医   91篇
植物保护   2篇
  2020年   3篇
  2019年   2篇
  2018年   2篇
  2017年   1篇
  2015年   1篇
  2014年   3篇
  2013年   4篇
  2012年   1篇
  2011年   3篇
  2010年   2篇
  2009年   3篇
  2007年   3篇
  2006年   4篇
  2005年   2篇
  2003年   7篇
  2002年   2篇
  2001年   4篇
  2000年   6篇
  1999年   9篇
  1998年   8篇
  1997年   11篇
  1996年   9篇
  1995年   2篇
  1994年   2篇
  1993年   3篇
  1992年   5篇
  1991年   4篇
  1990年   3篇
  1989年   6篇
  1988年   1篇
  1985年   1篇
  1983年   1篇
  1945年   2篇
  1936年   2篇
  1934年   1篇
  1930年   1篇
  1929年   2篇
  1924年   2篇
  1920年   1篇
  1919年   1篇
  1917年   2篇
  1911年   1篇
排序方式: 共有133条查询结果,搜索用时 31 毫秒
11.
12.
13.
Rapid flow cytometric analysis of the cell cycle in intact plant tissues   总被引:2,自引:0,他引:2  
Mechanical chopping of plant tissues in the presence of mithramycin released intact nuclei representative of the cells within the tissues. The amount of nuclear DNA in the homogenates of monocotyledonous and dicotyledonous plants was accurately and rapidly determined by flow microfluorometry, and the distribution of nuclei involved in the cell cycle was charted for tissues selected from different physical locations or developmental stages.  相似文献   
14.
15.
16.
17.
18.
19.
20.
REASON FOR PERFORMING STUDY: Trimetoquinol (TMQ) is a potent beta-adrenoceptor agonist bronchodilator used in human medicine but has not been evaluated for potential use as a therapeutic agent for horses with 'heaves'. OBJECTIVES: To assess the pharmacodynamics of TMQ in horses with 'heaves' to determine potential therapeutic effects. METHODS: Increasing doses of TMQ were administered to horses with 'heaves' by i.v. and intratracheal (i.t.) routes. Doses ranged 0.001-0.2 microg/kg bwt i.v. and 0.01-2 microg/kg bwt i.t. Cardiac and airways effects were assessed by measurement of heart rate (HR) and maximal change in pleural pressure (deltaPplmax), respectively. Side effects of sweating, agitation and muscle trembling were scored subjectively. Duration of action to i.v. (0.2 microg/kg bwt) and i.t. (2 microg/kg bwt) TMQ was evaluated over 6 h. RESULTS: Intravenous TMQ was an exceptionally potent cardiac stimulant. Heart rate increased at 0.01 microg/kg bwt, and was still increasing after administration of highest dose, 0.2 microg/kg bwt. Airway bronchodilation, measured as a decrease in deltaPplmax, also commenced at 0.01 microg/kg bwt. By the i.t. route, TMQ was 50-100-fold less potent than by i.v. Side effects included sweating, agitation and muscle trembling. Overall, the onset of HR and bronchodilator effects was rapid, within about 3 min, but effects were over at 2 h. CONCLUSION: When administered i.v. and i.t., TMQ is a highly potent cardiac stimulant and a modest bronchodilator. It may not be an appropriate pharmacological agent by i.v. and i.t. routes for the alleviation of signs in horses with 'heaves'. Further studies of TMQ by oral and aerosol routes are necessary. POTENTIAL RELEVANCE: In horses, TMQ is a fast-acting bronchodilator with a short duration of action. It could be used as a rescue agent during an episode of 'heaves'. The i.v. and i.t. administration of TMQ is associated with side effects, similar to those reported for all other beta-agonists. However, other routes, such as aerosol and oral, may prove useful and safe for the alleviation of bronchoconstriction typical of 'heaves'.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号